C. Costard

发表

Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism

T. Sulpice, F. Briand, M. Mark, 2016, Diabetes.

Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters.

T. Sulpice, S. Sordello, F. Briand, 2014, Atherosclerosis.

Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters.

T. Leste-Lasserre, R. Burcelin, T. Sulpice, 2021, Metabolism: clinical and experimental.

Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model.

R. Burcelin, T. Sulpice, F. Briand, 2020, European journal of pharmacology.